BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Sinclair Research
Xlumena is defunct.

Fate: Acquired by Boston Scientific April 2015, $62.5M


------------------
If you believe any of this information is incorrect, please let us know.